COMMUNIQUÉS West-GlobeNewswire

Emblem Corp. Reports Second Quarter 2018 Financial Results
22/08/2018
Revenues increase 180% over the quarter ended June 30, 2017 and 18% over Q1 2018 TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), a licensed producer of [...]
Avivagen Announces Vivamune Distribution Agreement for the GTA
22/08/2018
OTTAWA, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and [...]
MolecularMD Launches Validated Tumor Mutation Burden Assay for Immuno-Oncology Clinical Trial Services
22/08/2018
PORTLAND, Ore., Aug. 22, 2018 (GLOBE NEWSWIRE) -- MolecularMD today announces it has validated Thermo Fisher Scientific’s Oncomine™ Tumor Mutation Load Assay for clinical research trials to aid immunotherapy drug [...]
JSC “Grindeks” and Latvian Institute of Organic Synthesis sign cooperation agreement
22/08/2018
On Wednesday, August 22, the leaders of Latvian science and industry – JSC “Grindeks” and Latvian Institute of Organic Synthesis (IOS) – strengthened their long-lasting partnership with a new agreement, to reorient from [...]
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2018
22/08/2018
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2018 Biohit Oyj Half Year Financial Report 22 August 2018 at 9:30 am local time (EET) SUMMARY January-June 2018 Net sales EUR 4.9 million (EUR 4.1 million) which grew by 21.1% [...]
argenx announces that AbbVie has exercised its exclusive option to license ARGX-115, a novel immuno-oncology antibody
22/08/2018
Breda, the Netherlands/Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]
SOLON EIENDOM ASA - Strong results and sales in first half 2018
22/08/2018
Solon Eiendom ASA – Revenue increase of 36 % in the first half of 2018 compared to first half 2017. Total EBITDA (NGAAP) of NOK 156 million in the first half of 2018. (Oslo, Norway, 22 August 2018) Solon Eiendom ASA ( [...]
Saniona publishes its interim report for the second quarter 2018
22/08/2018
PRESS RELEASE August 22, 2018 Financial highlights H1 2018 (H1 2017) Net revenues were SEK 8.1 M (11.9 M) EBIT was SEK -39.9 M (-25.4 M) Net profit/loss was SEK -33.0 M (-21.1 M) Earnings per share were SEK -1.51 (-1.00 [...]
Half-Year Report January-June 2018
22/08/2018
Summary APRIL-JUNE IN BRIEF All planned submissions of clinical trial applications to health authorities and ethical committees for PledOx ® in Europe has been submitted. The European investigator meeting for the POLAR [...]
Interim Report Q2 2018: Continued double digit organic revenue growth drives strong EBITA margin increase. GN Audio upgrades organic growth guidance
22/08/2018
GN Store Nord delivered 11% organic revenue growth in Q2 2018. Revenue growth was 7% including around (5)% impact from development in foreign exchange rates EBITA margin increased 1.5 percentage points in Q2 2018 as a [...]
Kane Biotech Announces Second Quarter 2018 Financial Results
21/08/2018
WINNIPEG, Manitoba, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) announces its Second Quarter 2018 Financial Results. Kane Biotech Inc. is a [...]
Neon Therapeutics Appoints Jolie M. Siegel as General Counsel
21/08/2018
CAMBRIDGE, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the appointment of Jolie M. [...]
Rubius Therapeutics to Announce Second Quarter 2018 Financial Results
21/08/2018
CAMBRIDGE, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, plans to report second [...]
Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
21/08/2018
Total Fourth-Quarter Revenues of $200.9 Million Fourth-Quarter Diluted EPS of $0.18 and Adjusted EPS of $0.38, Up 31 Percent SALT LAKE CITY, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad [...]
Dermavant Sciences Announces Closing of Transaction With GSK for Purchase of Rights to Tapinarof
21/08/2018
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Dermavant Sciences, a subsidiary of Roivant Sciences, today announced the closing of its transaction with GSK, executed on July 10, 2018, for the purchase of all global rights [...]
NeuroMetrix Receives $3.8M Milestone Payment Under Its Collaboration with GSK Consumer Healthcare
21/08/2018
WALTHAM, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported that it had achieved the second development milestone under its strategic collaboration with GSK Consumer Healthcare. A [...]
The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada
21/08/2018
DENVER, Aug. 21, 2018 (GLOBE NEWSWIRE) -- What: The International Association for the Study of Lung Cancer (IASLC) presents the IASLC 19 th World Conference on Lung Cancer (WCLC) on September 23-26, 2018, in Toronto, [...]
NeoTherma Oncology Receives NCI Grant to Advance VectRx™ MRI Thermometry
21/08/2018
WICHITA, Kan., Aug. 21, 2018 (GLOBE NEWSWIRE) -- NeoTherma Oncology (NTO), developer of an advanced bioelectric medical device for noninvasive treatment of serious cancers, today announced the Company was recently [...]
InCrowd Named as Finalist for Vendor of the Year from PM360
21/08/2018
2018 Trailblazer Award Honors Vendors’ Commitment to The Life Sciences Through Innovation, Talent Development, Social Responsibility WATERTOWN, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- InCrowd , pioneer of the real-time [...]

Pages